Search

Find exactly what you’re looking for.
Search

Insights
Showing 1-7 of 7 results

The federal Corporate Transparency Act (“CTA”) requires that corporations submit a report to the Financial Crimes Enforcement Network (“FinCEN”) before January 1, 2025, with information on the persons who exercise substantial control over the corporation. As currently in place, condominium and...

Sherry Flax

Sherry Flax concentrates her practice on matters dealing with intellectual property law, with an emphasis on trademarks and copyrights. She assists clients in securing and protecting their rights in commercially valuable property through U.S. and international trademarks and copyrights, domain names...

Brian R. Landry

Brian Landry draws on a broad base of intellectual property experience involving patents, designs, trademarks, and copyrights and technical expertise to help clients identify, protect, and enforce their intellectual property. Brian has significant experience in the medical devices field as well as...

Mark Mizrahi

Mark Mizrahi advises clients on intellectual property law, including patent, trademark and copyright protection and enforcement. His experience includes preparing and managing trademark and copyright applications, preparing and negotiating licenses and agreements relating to intellectual property...

Counsel From the Earliest Stage of Development Through Disposition of Projects Throughout the continuum of financing, acquiring, developing, leasing and selling real estate are a multitude of complexities to address and challenges to overcome—from regulatory hurdles and shifting capital stacks to...

Counsel From the Earliest Stage of Development Through Disposition of Projects Throughout the continuum of financing, acquiring, developing, leasing and selling real estate are a multitude of complexities to address and challenges to overcome—from regulatory hurdles and shifting capital stacks to...

Jay Reilly Headshot

Jay Reilly represents biotech, medical device and diagnostic companies, as well as universities and nonprofits, in strategic transactions in the life sciences industry, particularly complex collaborative arrangements and technology acquisitions and dispositions. Jay has extensive experience...

For More Information
Contact us